Survivors of acute myocardial infarction (AMI) face a substantial excess risk of further cardiovascular events, including increased mortality. The prognosis varies markedly according to the presence of adverse risk factors. Risk stratif ication of patients with AMI begins upon presentation and is a continuous process to predict those who are at high risk for further ischemic events and who are at increased risk after discharge. Several risk scores have been developed over the past decade to assess short- and long-term outcomes after AMI. The most widely used is the Thrombolysis in Myocardial Infarction (TIMI) risk score to predict 14- to 30-day mortality [1].